Record-setting healthcare M&A activity to extend through H2: PwC
Seeking Alpha ·
Healthcare dealmaking is already at the highest level since the pandemic, and the momentum is expected to continue into H2 2026, driven by looming patent cliffs and consumer demand for areas such as women’s health and GLP-1s, PwC said this week in its
DYAX Investor Sentiment
Bullish (Long) 53% · Bearish (Short) 47%
311 participants